American Well (NYSE:AMWL) Insider Sells $34,801.02 in Stock

American Well Corporation (NYSE:AMWLGet Free Report) insider Phyllis Gotlib sold 3,573 shares of American Well stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $9.74, for a total value of $34,801.02. Following the completion of the transaction, the insider owned 159,431 shares of the company’s stock, valued at $1,552,857.94. The trade was a 2.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Phyllis Gotlib also recently made the following trade(s):

  • On Wednesday, April 1st, Phyllis Gotlib sold 3,706 shares of American Well stock. The shares were sold at an average price of $5.30, for a total value of $19,641.80.

American Well Stock Performance

Shares of AMWL opened at $8.73 on Friday. The stock has a 50-day simple moving average of $6.92 and a 200-day simple moving average of $5.56. The stock has a market capitalization of $144.40 million, a PE ratio of -1.61 and a beta of 1.69. American Well Corporation has a 1 year low of $3.71 and a 1 year high of $9.96.

American Well (NYSE:AMWLGet Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported ($0.66) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.77) by $0.11. The business had revenue of $54.88 million during the quarter, compared to analysts’ expectations of $51.54 million. American Well had a negative return on equity of 32.11% and a negative net margin of 37.02%. Analysts predict that American Well Corporation will post -2.68 EPS for the current year.

Institutional Investors Weigh In On American Well

Several institutional investors have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. lifted its stake in American Well by 16.5% during the second quarter. JPMorgan Chase & Co. now owns 14,720 shares of the company’s stock worth $131,000 after purchasing an additional 2,081 shares during the last quarter. Geode Capital Management LLC lifted its stake in American Well by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 152,742 shares of the company’s stock worth $750,000 after purchasing an additional 3,450 shares during the last quarter. State Street Corp lifted its stake in American Well by 7.8% during the fourth quarter. State Street Corp now owns 52,299 shares of the company’s stock worth $257,000 after purchasing an additional 3,800 shares during the last quarter. Headlands Technologies LLC purchased a new stake in American Well during the second quarter worth approximately $39,000. Finally, Two Sigma Investments LP lifted its stake in American Well by 22.6% during the third quarter. Two Sigma Investments LP now owns 46,329 shares of the company’s stock worth $285,000 after purchasing an additional 8,553 shares during the last quarter. Hedge funds and other institutional investors own 56.05% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on AMWL shares. Morgan Stanley lifted their price objective on American Well from $6.00 to $6.50 and gave the company an “equal weight” rating in a research note on Wednesday, May 6th. Wall Street Zen upgraded American Well from a “sell” rating to a “hold” rating in a research note on Sunday, March 22nd. Stifel Nicolaus decreased their price objective on American Well from $6.00 to $5.00 and set a “hold” rating for the company in a research note on Friday, February 13th. Finally, TD Cowen boosted their target price on American Well from $5.00 to $8.00 and gave the stock a “hold” rating in a research note on Wednesday, May 6th. One investment analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $7.13.

View Our Latest Stock Report on American Well

American Well Company Profile

(Get Free Report)

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.

Featured Articles

Insider Buying and Selling by Quarter for American Well (NYSE:AMWL)

Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.